IDEXX Laboratories, Inc. (IDXX)
NASDAQ: IDXX · Real-Time Price · USD
553.48
-4.45 (-0.80%)
Oct 21, 2026, 4:00 PM EDT - Market closed
IDEXX Laboratories Stock Forecast
Stock Price Forecast
According to 15 analysts polled by S&P Global, IDEXX Laboratories stock has a consensus rating of "Buy" and an average price target of $702.38. The average 1-year stock price forecast is 26.90% higher than the current stock price, while the lowest is $470 (-15.08%) and the highest is $805 (+45.44%).
Price Target: $702.38 (+26.90%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for IDEXX Laboratories stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 4 | 4 | 5 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 5 | 5 | 5 | 5 | 4 | 5 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 15 | 15 | 14 | 13 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Buy Reiterates $775 → $750 | Buy | Reiterates | $775 → $750 | +35.51% | Oct 16, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Initiates $740 | Buy | Initiates | $740 | +33.70% | Oct 16, 2026 |
| KeyBanc | KeyBanc | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Oct 12, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Oct 2, 2026 |
| UBS | UBS | Hold Reiterates $670 | Hold | Reiterates | $670 | +21.05% | Sep 16, 2026 |
Financial Forecast
Revenue This Year
4.72B
from 4.30B
Increased by 9.77%
Revenue Next Year
5.15B
from 4.72B
Increased by 8.99%
EPS This Year
14.84
from 13.08
Increased by 13.44%
EPS Next Year
16.76
from 14.84
Increased by 12.97%
EPS and Forward PE are based on non-GAAP adjusted numbers.